The Cooper Companies, Inc. income statement COO

In fiscal 2025, which ended Oct 31, 2025, The Cooper Companies, Inc. reported revenue of $4.1 billion, up 5.1% from the year before. Net income was $374.9 million, a profit margin of 9.2%. Operating income came to $682.9 million, an operating margin of 16.7%. Diluted earnings per share were $1.87. Over the twelve months ended Jul 31, 2026, revenue was $4.2 billion and net income was $570.3 million. Across the 10 fiscal years shown, revenue grew from $2.0 billion in fiscal 2016 to $4.1 billion in fiscal 2025, about 8.5% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2026
Jul 31, 2026
FY 2025
Oct 31, 2025
FY 2024
Oct 31, 2024
FY 2023
Oct 31, 2023
FY 2022
Oct 31, 2022
FY 2021
Oct 31, 2021
FY 2020
Oct 31, 2020
FY 2019
Oct 31, 2019
FY 2018
Oct 31, 2018
FY 2017
Oct 31, 2017
FY 2016
Oct 31, 2016
Revenue
4,237
+4.7%
4,092
+5.1%
3,895
+8.4%
3,593
+8.6%
3,308
+13.2%
2,922
+20.2%
2,431
-8.4%
2,653
+4.8%
2,533
+18.4%
2,139
+8.8%
1,967
+9.4%
Cost of revenue
1,444
+8.0%
1,410
+8.5%
1,300
+5.2%
1,235
+5.7%
1,169
+20.9%
967
+7.9%
896
-0.1%
897
-0.4%
900
+16.5%
773
-2.6%
794
+9.2%
Gross profit
2,793
+3.1%
2,682
+3.3%
2,596
+10.1%
2,358
+10.2%
2,140
+9.4%
1,956
+27.4%
1,535
-12.6%
1,757
+7.6%
1,632
+19.5%
1,366
+16.4%
1,173
+9.6%
Research and development
170
+0.8%
172
+11.0%
155
+12.9%
137
+24.6%
110
+19.0%
93
-0.6%
93
+7.6%
87
+2.2%
85
+22.5%
69
+5.8%
65
-6.0%
Selling, general and administrative
1,887
+17.9%
1,628
+6.1%
1,534
+2.2%
1,501
+11.8%
1,342
+10.8%
1,211
+22.0%
992
-0.4%
996
+2.4%
973
+21.8%
799
+10.6%
723
+1.4%
Operating income
544
-26.5%
683
-3.2%
706
+32.4%
533
+5.0%
508
+0.4%
506
+62.2%
312
-43.0%
547
+35.6%
403
-6.1%
429
+32.4%
324
+36.9%
Interest expense
89
-13.1%
100
-12.5%
114
—
—
—
—
—
—
—
—
Other non-operating income (expense)
7
+137.0%
-16
-80.2%
-9
+38.9%
-15
-159.6%
25
+184.1%
9
+203.5%
-8
-553.8%
-1
—
—
—
Pretax income
462
-25.2%
566
-2.7%
582
+41.0%
413
-13.1%
475
-3.3%
492
+84.4%
266
-44.2%
477
+43.8%
332
-15.8%
394
+33.3%
296
+37.2%
Income tax
-108
-151.3%
192
+0.8%
190
+60.1%
119
+32.6%
90
+103.6%
-2,453
-8830.2%
28
+162.6%
11
-94.4%
192
+810.0%
21
+1.9%
21
+99.0%
Net income
570
+39.8%
375
-4.4%
392
+33.3%
294
-23.7%
386
-86.9%
2,945
+1135.2%
238
-48.9%
467
+233.6%
140
-62.5%
373
+36.1%
274
+34.6%
Basic EPS
2.92
+42.8%
1.88
-4.6%
1.97
+32.2%
1.49
-23.6%
1.95
-96.7%
59.80
+1133.0%
4.85
-48.6%
9.44
+231.2%
2.85
-62.6%
7.63
+35.0%
5.65
+34.5%
Diluted EPS
2.91
+43.2%
1.87
-4.6%
1.96
+32.4%
1.48
-23.7%
1.94
-96.7%
59.16
+1129.9%
4.81
-48.4%
9.33
+232.0%
2.81
-62.6%
7.52
+34.5%
5.59
+35.0%
Weighted average shares, basic
195
-2.1%
199
+0.1%
199
+0.5%
198
+0.3%
197
+301.2%
49
+0.2%
49
-0.6%
49
+0.6%
49
+0.4%
49
+0.8%
48
+0.0%
Weighted average shares, diluted
196
-2.3%
200
-0.2%
200
+0.6%
199
+0.3%
199
+299.2%
50
+0.4%
50
-0.8%
50
+0.6%
50
+0.2%
50
+1.2%
49
-0.4%
Other measures
Depreciation and amortization
384
+3.8%
377
+0.6%
375
+2.0%
368
—
—
—
281
+2.1%
275
+46.0%
188
-5.0%
198
+3.6%
EBITDA
928
-16.4%
1,060
-1.9%
1,081
+20.0%
901
—
—
—
828
+22.0%
678
+9.8%
618
+18.2%
522
+22.0%
Interest coverage
6.10x
6.83x
6.17x
—
—
—
—
—
—
—
—
Margins
Gross margin
65.93%
65.54%
66.64%
65.62%
64.67%
66.92%
63.14%
66.21%
64.45%
63.85%
59.65%
Operating margin
12.84%
16.69%
18.12%
14.84%
15.34%
17.31%
12.83%
20.60%
15.92%
20.06%
16.48%
Pretax margin
10.91%
13.84%
14.95%
11.49%
14.37%
16.82%
10.96%
17.99%
13.10%
18.42%
15.03%
Profit margin
13.46%
9.16%
10.07%
8.19%
11.66%
100.76%
9.81%
17.59%
5.52%
17.43%
13.93%
EBITDA margin
21.91%
25.91%
27.75%
25.07%
—
—
—
31.19%
26.78%
28.87%
26.56%
Effective tax rate
-23.33%
33.82%
32.63%
28.75%
18.83%
-499.13%
10.54%
2.24%
57.85%
5.36%
7.00%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Ophthalmic Goods (SIC 3851)
Listed as
COO (Nasdaq)
Fiscal year ends
October 31
Incorporated in
DE
Headquarters
San Ramon, CA
SEC filer status
Large accelerated filer
SEC CIK
711404
Former names
COOPER COMPANIES INC (until Jun 26, 2019)

Other Ophthalmic Goods companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.